C4 Therapeutics Inc. (CCCC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    C4 Therapeutics Inc.

    NASDAQ: CCCC · Real-Time Price · USD
    2.27
    0.06 (2.71%)
    At close: Oct 03, 2025, 3:59 PM
    2.27
    0.00%
    After-hours: Oct 03, 2025, 07:37 PM EDT

    C4 Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 55.5M 126.59M 29.75M 76.12M
    Short-Term Investments
    		 189.41M 127.09M 246.4M 233.16M
    Long-Term Investments
    		 22.36M 28.01M 60.96M 142.2M
    Other Long-Term Assets
    		 6.1M 6.17M 4.8M 3.82M
    Receivables
    		 3.1M 11.8M 1.47M 5.72M
    Inventory
    		 n/a n/a -60.96M n/a
    Other Current Assets
    		 9.76M 5.71M 70.89M n/a
    Total Current Assets
    		 257.77M 271.19M 287.56M 325.69M
    Property-Plant & Equipment
    		 63.38M 71.09M 77.52M 35.05M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 91.83M 105.26M 143.28M 181.08M
    Total Assets
    		 349.6M 376.45M 430.84M 506.76M
    Account Payables
    		 1.33M 1.45M 1.17M 4.51M
    Deferred Revenue
    		 18.71M 15.47M 16.62M 31.8M
    Short-Term Debt
    		 n/a 5.22M 2.29M 1.33M
    Other Current Liabilities
    		 9.3M 8.07M 3.11M 7.19M
    Total Current Liabilities
    		 45.18M 42.77M 44.55M 51.25M
    Long-Term Debt
    		 n/a n/a 9.2M 10.77M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 88.44M 87.57M 97.06M 65.91M
    Total Liabilities
    		 133.62M 130.34M 141.61M 117.16M
    Total Debt
    		 65.76M 70.98M 87.15M 42.88M
    Book Value
    		 215.99M 246.11M 289.23M 389.61M
    Book Value Per Share
    		 3.11 4.96 5.92 8.46
    Common Stock
    		 7K 6K 5K 5K
    Retained Earnings
    		 -633.7M -528.38M -395.89M -267.71M
    Comprehensive Income
    		 53K -127K -4.14M -775K
    Shareholders Equity
    		 215.99M 246.11M 289.23M 389.61M
    Total Investments
    		 211.76M 155.1M 307.36M 375.36M

    Add to Watchlist